Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,860,851
+$116,520 QoQ
Shares Held
15,202
-0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#1,801
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026King Wealth Management Group holds $17,091,631 across 9 Drug Manufacturers - General names. JNJ ranks #2 (22.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,913 | $9,491,090 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
15,202 | $3,860,851 | |
| 3 | MRK |
Merck & Co., Inc.
|
7,948 | $1,021,318 | |
| 4 | ABBV |
AbbVie Inc.
|
2,709 | $681,692 | |
| 5 | NVS |
Novartis AG
|
3,251 | $509,496 | |
| 6 | PFE |
Pfizer Inc
|
19,427 | $467,802 | |
| 7 | AMGN |
Amgen Inc
|
1,179 | $426,939 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,843 | $394,293 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,860,851 | 15,202 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $3,744,331 | 15,318 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $3,124,945 | 15,100 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,706,761 | 14,598 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,249,702 | 14,728 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,562,559 | 15,452 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,249,997 | 15,558 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,470,442 | 15,244 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $7,042,427 | 48,183 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $7,944,934 | 50,224 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $8,190,918 | 52,258 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $8,321,099 | 53,426 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $8,779,677 | 53,043 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $8,090,225 | 52,195 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $9,157,536 | 51,840 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $8,471,032 | 51,855 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $9,166,616 | 51,640 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $9,715,925 | 54,821 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $9,605,067 | 56,147 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $8,952,106 | 55,431 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $9,014,408 | 54,719 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $8,911,221 | 54,221 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $9,059,579 | 57,565 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $8,391,472 | 56,364 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $6,414,415 | 45,612 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,619,190 | 19,974 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||